ASP Isotopes

ASPI

Market cap $806M

Overview Fund Activity

8.77 USD

+0.12

1.39%

At close Updated Sep 12, 4:00 PM EDT

Pre-market

After hours

8.80

+0.03

0.34%

1 day

1.39%

5 days

5.03%

1 month

-21.77%

3 months

4.9%

6 months

113.38%

Year to date

77.53%

1 year

224.81%

5 years

228.46%

10 years

228.46%

About: ASP Isotopes Inc is a pre-commercial stage materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.

Employees: 136

Materials Chemicals

0

Funds holding %

of 7,462 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

229% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 14

114% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 22

101% more capital invested

Capital invested by funds: $152M [Q1] → $305M (+$153M) [Q2]

33% more funds holding

Funds holding: 95 [Q1] → 126 (+31) [Q2]

12% more call options, than puts

Call options by funds: $24.2M | Put options by funds: $21.6M

3.97% more ownership

Funds ownership: 45.39% [Q1] → 49.37% (+3.97%) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 3 [Q1] → 3 (+0) [Q2]

See Fund Rankings

Financial journalist opinion

Based on 5 articles about ASPI published over the past 30 days

Nuclear Power Industry Veteran Ralph Hunter Joins Board of Directors of ASP Isotopes Inc. and Board of Managers of Quantum Leap Energy LLC

WASHINGTON, Sept. 08, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced the appointment of Ralph L. Hunter, Jr. to the board of directors of ASP Isotopes and the board of managers of Quantum Leap Energy LLC.

Nuclear Power Industry Veteran Ralph Hunter Joins Board of Directors of ASP Isotopes Inc. and Board of Managers of Quantum Leap Energy LLC

I Now See Chemistry Can Be Hip: I Can't Buy An Isotope, But I Can Buy ASP Isotopes Stock

In my younger days, I really hated chemistry, especially having to memorize the Periodic Table of elements. That was pre-internet. Does anyone still do that? Last year, I discovered how interesting the adult version of this field can be – especially when it comes to enriching isotopes. That's what ASP Isotopes (ASPI) does. Skipping the geeky details, we can create all sorts of interesting new materials based on human-generated high concentrations of oddball variations in certain atoms.

I Now See Chemistry Can Be Hip: I Can't Buy An Isotope, But I Can Buy ASP Isotopes Stock

ASP Isotopes Issues Letter to Shareholders

WASHINGTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today released the following letter to shareholders from its Chairman and CEO, Paul Mann.

ASP Isotopes Issues Letter to Shareholders

ASP Isotopes Inc. Hosts South African Investors in Advance of Secondary Listing on the Johannesburg Stock Exchange (JSE) and Provides Updates on its Isotope Production Plants

- ASP Isotopes will host an investor access event on Tuesday, August 26, 2025 at its Pretoria facilities for approximately 30 South African investors.

ASP Isotopes Inc. Hosts South African Investors in Advance of Secondary Listing on the Johannesburg Stock Exchange (JSE) and Provides Updates on its Isotope Production Plants

Fermi America™ and ASP Isotopes Join Forces to Secure America's Advanced Reactor Fuel Supply

- Texas-based private grid campus to host one of the first U.S. HALEU enrichment facilities, strengthening energy security and reducing reliance on foreign sources AMARILLO, Texas , Aug. 15, 2025 /PRNewswire/ -- Fermi America, developer of the 11 GW private grid campus for next-generation hyperscale AI in collaboration with the Texas Tech University System, today announced it has signed a Memorandum of Understanding (MOU) with ASP Isotopes Inc. (NASDAQ: ASPI) and its subsidiary Quantum Leap Energy LLC (QLE) to explore the development of a High Assay Low Enriched Uranium (HALEU) enrichment facility at Fermi America's site in Carson County, Texas. The planned facility would use advanced laser-based isotope separation technology to produce HALEU — a specialized nuclear fuel essential for many Generation IV and small modular reactor (SMR) designs.

Fermi America™ and ASP Isotopes Join Forces to Secure America's Advanced Reactor Fuel Supply

ASP Isotopes Inc. Announces Expected Commencement of Dual Listing on Johannesburg Stock Exchange

WASHINGTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today provided an update on its application to list on the Johannesburg Stock Exchange (“JSE”).

ASP Isotopes Inc. Announces Expected Commencement of Dual Listing on Johannesburg Stock Exchange

ASP Isotopes Inc. and IsoBio, Inc. Announce Series Seed Funding of IsoBio, Inc. to Advance Innovative Antibody-Isotope Conjugates (AICsTM) For Cancer Treatment

- IsoBio, Inc. (IsoBio) is a U.S.-based radiotherapeutic development company focused on developing a broad pipeline of mAb-based radioisotope therapeutics, known as antibody-isotope conjugates (AICs TM ), targeting both derisked and novel tumor antigens for patients in need of new cancer therapies.

ASP Isotopes Inc. and IsoBio, Inc. Announce Series Seed Funding of IsoBio, Inc. to Advance Innovative Antibody-Isotope Conjugates (AICsTM) For Cancer Treatment

Competition Commission of South Africa Approves the Offer by ASP Isotopes Inc. for Renergen Limited

WASHINGTON, D.C., July 25, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that the Company's proposed offer to acquire all of the issued ordinary shares of JSE-listed Renergen Limited (“Renergen”) has been approved as of July 23, 2025, by the Competition Commission of South Africa, subject to certain conditions, which are acceptable to the Company.

Competition Commission of South Africa Approves the Offer by ASP Isotopes Inc. for Renergen Limited

ASP Isotopes Inc. Announces Pricing of $60 Million Underwritten Registered Direct Offering of Common Stock

WASHINGTON, July 23, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), today announced the pricing of an underwritten registered direct offering of 7,500,000 shares of its common stock at a price of $8.00 per share to a single fundamental institutional investor. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $60.0 million. The offering is expected to close on or about July 25, 2025, subject to the satisfaction of customary closing conditions.

ASP Isotopes Inc. Announces Pricing of $60 Million Underwritten Registered Direct Offering of Common Stock

Shareholders of Renergen Limited Approve Proposed Acquisition by ASP Isotopes Inc.

WASHINGTON, July 11, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that at a general meeting of shareholders of Renergen Limited (“Renergen”) held on July 10, 2025, Renergen shareholders voted overwhelmingly in favor of the acquisition of Renergen by ASP Isotopes through a scheme of arrangement (the “Scheme”) in accordance with Sections 114 and 115 of the South African Companies Act, No. 71 of 2008. The Scheme received support from 99.80% of voting shareholders.

Shareholders of Renergen Limited Approve Proposed Acquisition by ASP Isotopes Inc.

See News Rankings

Charts implemented using Lightweight Charts™